tiprankstipranks
Advertisement
Advertisement
Yazdi Reiterates Buy on Sionna, Keeps $58 Price Target Ahead of High-Impact 2026 SION-719 Readout
PremiumRatingsYazdi Reiterates Buy on Sionna, Keeps $58 Price Target Ahead of High-Impact 2026 SION-719 Readout
1M ago
Sionna Therapeutics reports Q1 EPS (60c), consensus (50c)
Premium
The Fly
Sionna Therapeutics reports Q1 EPS (60c), consensus (50c)
1M ago
Vertex Pharmaceuticals price target lowered to $572 from $577 at Bernstein
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $572 from $577 at Bernstein
1M ago
Sionna Therapeutics price target raised to $50 from $45 at Guggenheim
PremiumThe FlySionna Therapeutics price target raised to $50 from $45 at Guggenheim
3M ago
Sionna Therapeutics files automatic mixed securities shelf
Premium
The Fly
Sionna Therapeutics files automatic mixed securities shelf
3M ago
Sionna Therapeutics files automatic mixed securities shelf
Premium
The Fly
Sionna Therapeutics files automatic mixed securities shelf
3M ago
Sionna Therapeutics price target raised to $58 from $50 at BTIG
PremiumThe FlySionna Therapeutics price target raised to $58 from $50 at BTIG
5M ago
Sionna Therapeutics price target raised to $58 from $50 at BTIG
Premium
The Fly
Sionna Therapeutics price target raised to $58 from $50 at BTIG
5M ago
Coty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
Premium
The Fly
Coty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100